InsiderClue
Insiders · Profile

Meckler Jeffrey A

Director at Travere Therapeutics · CEO and Director at Indaptus Therapeutics · CHIEF EXECUTIVE OFFICER at Cocrystal Pharma. Filing since 25 Nov 2014. CIK 0001506916

TVTX Travere Therapeutics, Inc. Director · 6 trades INDP Indaptus Therapeutics, Inc. CEO and Director · 8 trades COCP Cocrystal Pharma, Inc. CHIEF EXECUTIVE OFFICER · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TVTX Travere Therapeutics, Inc.
10 Sep 2026
Director
Sold on a plan
20,000
$1.35M
17.9%
TVTX Travere Therapeutics, Inc.
4 May 2026
Director
Sold on a plan
8,000
$360.00K
8.4%
TVTX Travere Therapeutics, Inc.
30 Sep 2024
Director
Sold on a plan
40,000
$562.32K
33.1%
INDP Indaptus Therapeutics, Inc.
21 Nov 2022
CEO and Director
Bought
9,600
$18.24K
14.6%
INDP Indaptus Therapeutics, Inc.
18 Nov 2022
CEO and Director
Bought
400
$705.48
0.6%
INDP Indaptus Therapeutics, Inc.
8 Sep 2022
CEO and Director
Bought
10,308
$28.86K
18.7%
INDP Indaptus Therapeutics, Inc.
7 Sep 2022
CEO and Director
Bought
8,632
$22.18K
18.6%
INDP Indaptus Therapeutics, Inc.
6 Sep 2022
CEO and Director
Bought
1,060
$2.59K
2.3%
INDP Indaptus Therapeutics, Inc.
6 Jun 2022
CEO and Director
Bought
19,727
$51.88K
76.9%
INDP Indaptus Therapeutics, Inc.
18 Nov 2021
CEO and Director
Bought
11,187
$65.11K
77.4%
INDP Indaptus Therapeutics, Inc.
14 Sep 2021
CEO and Director
Bought
12,000
$84.00K
488%
COCP Cocrystal Pharma, Inc.
15 Mar 2016
CHIEF EXECUTIVE OFFICER
Bought
294,118
$150.00K
81.0%
TVTX Travere Therapeutics, Inc.
4 Mar 2016
Director
Bought
5,000
$76.56K
10.6%
TVTX Travere Therapeutics, Inc.
3 Mar 2016
Director
Bought
10,000
$144.50K
27.0%
COCP Cocrystal Pharma, Inc.
23 Dec 2015
CHIEF EXECUTIVE OFFICER
Bought
100,000
$57.87K
38.0%
COCP Cocrystal Pharma, Inc.
25 Mar 2015
Director
Bought
163,043
$150.00K
163%
COCP Cocrystal Pharma, Inc.
11 Dec 2014
Director
Bought
100,000
$45.61K
opened
TVTX Travere Therapeutics, Inc.
25 Nov 2014
Director
Bought
15,000
$129.05K
75.0%
18 decisions on file.